Leerink Partners, Global Healthcare and Pliant Therapeutics

Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference
SLN ("Silence" or the "Company"), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced that management will present a company overview at the Leerink Partners Global Healthcare Conference on Wednesday,
Leerink Partners Downgrades Pliant Therapeutics (PLRX)
Fintel reports that on March 3, 2025, Leerink Partners downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX) from Outperform to Market Perform. Analyst Price Forecast Suggests 1,110.33% Upside As of March 4,
Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference
A live audio webcast of the fireside chat can be accessed through the Investors section of the Company’s website at www.mereobiopharma.com/investors. An archived replay of the webcast will be available on the Company’s website for two weeks following the live event.
Werewolf Therapeutics to Present at the 2025 Leerink Partners Global Biopharma Conference
Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions,
Larimar Therapeutics to Present at Leerink Partners Global Healthcare Conference
BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) has announced its participation in the upcoming Leerink Partners Global Healthcare Conference, scheduled to take place in Miami Beach, Florida,
Dentsply Sirona to Participate in the Leerink Partners Global Healthcare Conference 2025
Investors and other interested parties will be able to access a live audio webcast and an audio webcast replay by visiting the Investors section of the Dentsply Sirona website at Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies,
AbbVie to Present at the Leerink Partners Global Healthcare Conference
AbbVie (NYSE: ABBV) will participate at the Leerink Partners Global Healthcare Conference on Tuesday, March 11, 2025. Management will participate in a fireside chat at 7:40 a.m. Central time.
MindMed to Present at Leerink’s Global Healthcare Conference 2025
An announcement from Mind Medicine ( ($MNMD) ) is now available. MindMed has announced its participation in Leerink’s Global Healthcare Conference
Fintel on MSN21h
Leerink Partners Downgrades Lexicon Pharmaceuticals (LXRX)
Fintel reports that on March 4, 2025, Leerink Partners downgraded their outlook for Lexicon Pharmaceuticals (NasdaqGS:LXRX) ...
Leerink Partners Sticks to Its Hold Rating for Amgen (AMGN)
In a report released on March 2, David Risinger from Leerink Partners maintained a Hold rating on Amgen (AMGN – Research Report). The company’s ...
Leerink Partners Lowers Recursion Pharmaceuticals (NASDAQ:RXRX) Price Target to $6.00
Recursion Pharmaceuticals (NASDAQ:RXRX – Get Free Report) had its target price dropped by Leerink Partners from $7.00 to ...
Fierce Pharma16d
Leerink group goes beyond conventional metrics to evaluate cost-effectiveness of key therapies
Over the last decade, as the Institute for Clinical and Economic Review (ICER) has estimated the cost-effectiveness of newly approved drugs—and often declared them overpriced—companies in the indus | ...
Business Wire2d
Contineum Therapeutics to Present at the 2025 Leerink Partners Global Healthcare Conference
today announced that management is scheduled to present at the 2025 Leerink Partners Global Healthcare Conference on Tuesday, March 11 th at 3:00 p.m. ET. An audio webcast of the presentation can ...
Leerink Partners Downgrades Pliant Therapeutics (NASDAQ:PLRX) to Market Perform
Pliant Therapeutics (NASDAQ:PLRX – Get Free Report) was downgraded by research analysts at Leerink Partners from an “outperform” rating to a “market perform” rating in a report released on Monday, ...
Molecular Partners Announces Participation at Upcoming Investor Conferences and 2024 Financial Results Conference Call
Participation in fireside chats at TD Cowen and Leerink healthcare conferencesCall on 2024 financial results on March 7 at 2.00 pm CET (8.00 am ...
Business Wire7d
Innate Pharma to Participate in the 2025 Leerink Partners Global Healthcare Conference
(“Innate” or the “Company”) today announced that members of its executive team will present and host 1x1 meetings at the Leerink Partners 2025 Global Healthcare Conference being held on ...